Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | TXN | P10599 | 1/20 | 0.36 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 7/20 | 0.35 |
| ▸ | HTR1A | P08908 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | NISCH | Q9Y2I1 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | MTOR | P42345 | 1/20 | 0.31 |
| ▸ | ADK | P55263 | 1/20 | 0.31 |
| ▸ | TERT | O14746 | 1/20 | 0.31 |
| ▸ | F2RL1 | P55085 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28443985 | 0.82 | ALDH1A1 (0.39) | ALDH1A1SMN1; SMN2TXNTXNRD1TAAR1 | |
| SCHEMBL28449449 | 0.79 | CYP1A2 (0.41) | ALDH1A1SMN1; SMN2TXNTXNRD1TAAR1 | |
| SCHEMBL207 | 0.72 | — | — | |
| SCHEMBL15140518 | 0.72 | ALDH1A1 (0.48) | ALDH1A1SMN1; SMN2TXNTXNRD1TAAR1 | |
| SCHEMBL3174030 | 0.71 | ALDH1A1 (0.38) | ALDH1A1SMN1; SMN2TXNTXNRD1TAAR1 | |
| SCHEMBL253735 | 0.71 | ALDH1A1 (0.33) | ALDH1A1SMN1; SMN2ALOX15 | |
| SCHEMBL1374565 | 0.71 | ALDH1A1 (0.46) | ALDH1A1SMN1; SMN2TAAR1NISCHALOX15 | |
| SCHEMBL1551505 | 0.69 | CYP3A4 (0.40) | ALDH1A1SMN1; SMN2TXNTXNRD1TAAR1 | |
| SCHEMBL28418820 | 0.68 | — | — | |
| SCHEMBL4964412 | 0.67 | ALDH1A1 (0.42) | ALDH1A1SMN1; SMN2TAAR1NISCHALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022256490-A9 | IMPROVED SYNTHESIS OF PHOSPHORAMIDATES FOR THE TREATMENT OF HEPATITIS B VIRUS | Antios Therapeutics, Inc. (US) | 2023-08-17 | — | — | WO | claimed |
| CN-115458809-A | Electrolyte and lithium ion battery comprising same | 香河昆仑新能源材料股份有限公司 | 2022-12-09 | — | — | CN | claimed |
| CN-111584841-B | Composite material, preparation method thereof and water-based lithium ion battery | 宁波锋成纳米科技有限公司 | 2021-07-27 | — | — | CN | claimed |
| CN-111584841-A | Composite material, preparation method thereof and water-based lithium ion battery | 宁波锋成纳米科技有限公司 | 2020-08-25 | — | — | CN | claimed |
| CN-109476525-A | The preparation method for the silica preform applied in production optical fiber | 普睿司曼股份公司 | 2019-03-15 | — | — | CN | claimed |
| WO-2023243720-A1 | METHOD FOR PRODUCING SILANE-CONTAINING CONDENSED RING DIPEPTIDE COMPOUND | 学校法人中部大学 | 2023-12-21 | — | — | WO | disclosed |
| CN-115458809-A | Electrolyte and lithium ion battery comprising same | 香河昆仑新能源材料股份有限公司 | 2022-12-09 | — | — | CN | disclosed |
| WO-2022190486-A1 | SILANE-CONTAINING CONDENSED CYCLIC DIPEPTIDE COMPOUND, PRODUCTION METHOD THEREFOR, AND METHOD FOR PRODUCING POLYPEPTIDE COMPOUND USING SAME | 学校法人中部大学 | 2022-09-15 | — | — | WO | disclosed |
| CN-111584841-B | Composite material, preparation method thereof and water-based lithium ion battery | 宁波锋成纳米科技有限公司 | 2021-07-27 | — | — | CN | disclosed |
| CN-111584841-A | Composite material, preparation method thereof and water-based lithium ion battery | 宁波锋成纳米科技有限公司 | 2020-08-25 | — | — | CN | disclosed |
| CN-104203984-B | The manufacture method of hydroxy alkylated polyrotaxane | 宇部兴产株式会社 | 2018-02-16 | — | — | CN | disclosed |
| US-20030216441-A1 | Farnesyltransferase inhibitors | WEINSTOCK, STEVEN F. | 2003-11-20 | — | — | US | disclosed |
| US-6380378-B1 | BIOSYNTHESIS | TOAGOSEI COMPANY, LTD. (JP) | 2002-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030216441-A1 | Farnesyltransferase inhibitors | FNTA, FNTB, LCAT | ALDH1A1 665/4885SMN1; SMN2 4512/4885TXN 2232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.